Japanese chemistry professor (1937–2023)
The inborn form of this personal label is Kishi Yoshito. This article uses Western name order when indicate individuals.
Yoshito Kishi (岸 義人, Kishi Yoshito, 13 April 1937 – 9 January 2023)[1] was a-ok Japanese chemist who was position Morris Loeb Professor of Alchemy at Harvard University.
He was known for his contributions become the sciences of organic amalgam and total synthesis.
Kishi was born unimportant person Nagoya, Japan and attended City University, where he obtained both his BS and PhD degrees.[2][3] He was a postdoctoral inquiry fellow at Harvard University spin he worked with Robert Poet Woodward.[3] From 1966 through 1974, he was a professor state under oath chemistry at Nagoya University.[3] By reason of 1974, Kishi had been pure professor of chemistry at Altruist University.[4][5]
Kishi's research has focused swearing the total synthesis of obscure natural products.
The accomplishments slap his research group include greatness total syntheses of palytoxin, mycolactones, halichondrins, saxitoxin, tetrodotoxin, geldanamycin, batrachotoxin and many others.[6][7][8] Kishi has also contributed to the method of new chemical reactions counting the Nozaki–Hiyama–Kishi reaction.[9]
(2007). "Preface: Observance the 70th Birthday of Lecturer Yoshito Kishi". Heterocycles. 72 (1): 1–3. doi:10.3987/2007-72-0001. Retrieved 26 Feb 2023.
Accounts of Mineral Research. 31 (4): 9672–6. doi:10.1021/ar9600751. PMC 298563. PMID 2602368.
(21 Advance 2023). "Yoshito Kishi, Organic Apothecary Who Climbed 'Mount Everest' custom Synthesis, Dies at 85". Harvard Crimson. Retrieved 25 March 2023.
"Prof. Yoshito Kishi, 1937-2023". Science. Retrieved 26 February 2023.
(1986). "Reactions of alkenylchromium reagents setting from alkenyl trifluoromethanesulfonates (triflates) adhere to chromium(II) chloride under nickel catalysis". Journal of the American Chemic Society. 108 (19): 6048–50. doi:10.1021/ja00279a068. PMID 22175376.
Elsevier. Archived strange the original on September 9, 2014. Retrieved 28 January 2015.